The expanded approval intensifies the rivalry with Jazz Pharmaceuticals, which has previously attempted to block Lumryz’s ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Avadel Pharmaceuticals (AVDL – Research ...

The FDA approves AVDL's Lumryz for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients aged seven ...

Surgeons at a Kentucky hospital were preparing to remove the organs from a donor who had been declared dead only to realize ...

Lumryz is an extended-release formulation of sodium oxybate, a central nervous system (CNS) depressant. Its therapeutic effects are believed to be mediated through GABA B actions at noradrenergic and ...

Avadel's drug contains a central nervous system depressant drug called sodium oxybate, which helps increase the amount of ...

A summary of recent health news updates reveals declining Marburg cases in Rwanda, Texas suing a doctor over prescribing ...

This invaluable filing allows investors to see what Wall Street's smartest money managers bought and sold in the latest ...